Stocks to Watch: Cipla, Ambuja Cements, and Paytm in Focus
Get the latest updates on the Indian stock market, including stocks to watch, corporate announcements, and market trends.
Blog
Blog
Pine Labs Shares Under Spotlight: Morgan Stanley Initiates Coverage with Rs 260 Target Price
Morgan Stanley has initiated coverage on Pine Labs Ltd with an ‘Equal-Weight’ rating and a target price of Rs 260, citing the company’s favourable market position and transition towards profitability.
Blog
Stock Market Live Updates: Nifty Levels, Q1 Results, and Top Stocks to Watch
Get the latest updates from the Indian stock markets, including Nifty levels, Q1 results, and major corporate actions affecting investor sentiment. Stay ahead with our in-depth analysis and expert insights.
Blog
Nifty Technical Analysis: Understanding Market Trends and Making Informed Decisions
Get insights into the Nifty’s technical charts and learn how to make informed investment decisions with our expert analysis and trading strategies.
Blog
Nifty Locked in Consolidation Phase: What to Expect from Indian Markets
The Nifty 50 index is currently locked in a consolidation phase, with the broader range demarcated between 26,220 on the upside and 25,700 on the downside. Here’s what investors can expect from Indian markets.
Blog
Indian Stock Market Update: TCS and Infosys Lead Gainers, Market Cap Surges Rs 75,257 Crore
The combined market valuation of six of the top-10 most-valued firms climbed Rs 75,256.97 crore last week, with Tata Consultancy Services and Infosys emerging as the biggest winners.
Blog
Gold and Silver Prices May Take a Breather Ahead of US Data Release
Gold and silver prices are expected to take a breather next week as investors turn cautious ahead of key US macroeconomic data, including GDP numbers, while thin year-end trading volumes limit price movements.
Blog
SEBI Clarifies No Change In Short Selling Regulatory Framework
SEBI clarifies that there is no change in the existing regulatory framework for short selling, amid media reports of potential changes from December 22, 2025.
Blog
Nifty Pharma Index Underperforms in 2025: A Stock-Picker’s Market
The Nifty Pharma index slipped nearly 3% in 2025 due to US pricing pressure, regulatory worries, and trade jitters. However, some pharma stocks delivered double-digit gains, rewarding investors who looked beyond the index.
Blog
Asian Stocks Poised for Year-End Rally: Market Analysis and Insights
Asian equity markets are set to climb on hopes of a year-end rally, tracking gains in US stocks. Get the latest updates and insights on the market trends and what they mean for Indian investors.